CORRECTION -- MariMed Expands Access to Top-Selling Betty’s Eddies Brand in Maine
MariMed (OTCQX: MRMD) has announced a new licensing agreement with The Stoned Moose to expand distribution of its Betty's Eddies™ full-spectrum fruit chews in Maine's $455 million cannabis market. The partnership will extend the brand's reach to include both adult-use and medical cannabis consumers, with medical sales representing over half of Maine's cannabis revenues in 2024.
Previously available only to adult-use consumers since 2022, Betty's Eddies will now be accessible to medical cannabis patients through The Stoned Moose's dual-license capabilities. The brand currently holds market leadership in edibles across Massachusetts, Maryland, and Delaware, targeting Maine's local consumer base and its 15 million annual tourists.
MariMed (OTCQX: MRMD) ha annunciato un nuovo accordo di licenza con The Stoned Moose per espandere la distribuzione delle sue caramelle alla frutta a spettro completo Betty's Eddies™ nel mercato della cannabis del Maine, del valore di 455 milioni di dollari. La collaborazione estenderà la presenza del marchio includendo sia i consumatori di cannabis per uso adulto che quelli per uso medico, con le vendite mediche che rappresentano oltre la metà dei ricavi della cannabis nel Maine nel 2024.
Disponibili in precedenza solo per i consumatori per uso adulto dal 2022, le Betty's Eddies saranno ora accessibili anche ai pazienti di cannabis medica grazie alle capacità di doppia licenza di The Stoned Moose. Il marchio detiene attualmente la leadership di mercato negli edibili in Massachusetts, Maryland e Delaware, mirando alla clientela locale del Maine e ai suoi 15 milioni di turisti annuali.
MariMed (OTCQX: MRMD) ha anunciado un nuevo acuerdo de licencia con The Stoned Moose para expandir la distribución de sus gomitas de fruta de espectro completo Betty's Eddies™ en el mercado del cannabis de Maine, valorado en 455 millones de dólares. La asociación ampliará el alcance de la marca para incluir tanto a consumidores de cannabis para uso adulto como médico, con las ventas médicas representando más de la mitad de los ingresos del cannabis en Maine en 2024.
Anteriormente disponibles solo para consumidores de uso adulto desde 2022, Betty's Eddies ahora estarán accesibles para pacientes de cannabis medicinal gracias a las capacidades de licencia dual de The Stoned Moose. La marca actualmente lidera el mercado de comestibles en Massachusetts, Maryland y Delaware, enfocándose en la base de consumidores local de Maine y sus 15 millones de turistas anuales.
MariMed (OTCQX: MRMD)는 The Stoned Moose와 새로운 라이선스 계약을 체결하여 메인 주의 4억 5,500만 달러 규모의 대마초 시장에서 Betty's Eddies™ 전 스펙트럼 과일 츄잉캔디의 유통을 확대한다고 발표했습니다. 이번 파트너십은 성인용 및 의료용 대마초 소비자 모두를 대상으로 브랜드의 범위를 확장할 예정이며, 2024년 메인 주 대마초 수익의 절반 이상이 의료용 판매에서 발생할 것으로 예상됩니다.
2022년부터 성인용 소비자에게만 제공되었던 Betty's Eddies는 이제 The Stoned Moose의 이중 라이선스 역량을 통해 의료용 대마초 환자에게도 제공됩니다. 이 브랜드는 현재 매사추세츠, 메릴랜드, 델라웨어에서 식용 제품 시장을 선도하고 있으며, 메인 주의 지역 소비자와 연간 1,500만 명의 관광객을 대상으로 하고 있습니다.
MariMed (OTCQX : MRMD) a annoncé un nouvel accord de licence avec The Stoned Moose afin d'étendre la distribution de ses bonbons fruités à spectre complet Betty's Eddies™ sur le marché du cannabis du Maine, estimé à 455 millions de dollars. Ce partenariat permettra à la marque d'élargir sa portée pour inclure à la fois les consommateurs de cannabis à usage adulte et médical, les ventes médicales représentant plus de la moitié des revenus du cannabis dans le Maine en 2024.
Jusqu'à présent disponibles uniquement pour les consommateurs adultes depuis 2022, les Betty's Eddies seront désormais accessibles aux patients de cannabis médical grâce aux capacités de double licence de The Stoned Moose. La marque détient actuellement la position de leader sur le marché des comestibles dans le Massachusetts, le Maryland et le Delaware, ciblant la clientèle locale du Maine ainsi que ses 15 millions de touristes annuels.
MariMed (OTCQX: MRMD) hat eine neue Lizenzvereinbarung mit The Stoned Moose bekannt gegeben, um die Distribution seiner Betty's Eddies™ Vollspektrum-Fruchtkaubonbons im 455 Millionen Dollar schweren Cannabismarkt von Maine auszubauen. Die Partnerschaft wird die Markenreichweite auf sowohl Freizeit- als auch medizinische Cannabiskonsumenten erweitern, wobei der medizinische Verkauf im Jahr 2024 über die Hälfte der Cannabisumsätze in Maine ausmacht.
Bislang seit 2022 nur für Freizeitkonsumenten erhältlich, werden Betty's Eddies nun auch für medizinische Cannabispatienten über die Dual-Lizenzierung von The Stoned Moose zugänglich sein. Die Marke führt derzeit den Markt für essbare Cannabisprodukte in Massachusetts, Maryland und Delaware an und richtet sich an die lokale Verbraucherschaft von Maine sowie an die 15 Millionen jährlichen Touristen.
- Expansion into both medical and adult-use cannabis markets in Maine
- Access to Maine's significant medical cannabis market which represents over 50% of state cannabis revenues
- Potential to reach 15 million annual tourists in Maine
- Brand already holds market leadership in edibles across multiple states
- Financial terms of the licensing agreement not disclosed
NORWOOD, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD) today announced a licensing agreement with The Stoned Moose, LLC (“The Stoned Moose”), a vertically integrated cannabis operator in Maine. This partnership will significantly expand the distribution of the Company’s top-selling Betty’s Eddies™ full-spectrum fruit chews in the
Betty’s Eddies has been available exclusively to adult-use cannabis consumers in Maine since 2022 through a former licensing partner. The new agreement with The Stoned Moose, which owns a license that allows for both adult-use and medical cannabis distribution, will enable the state’s medical cannabis patients to purchase the brand as well. Medical cannabis sales accounted for more than half of Maine’s cannabis revenues in 2024.
“We are excited to work with The Stoned Moose to expand the availability of Betty’s Eddies to all cannabis consumers and patients in Maine, including the 15 million tourists who visit the state annually,” said Jon Levine, Chief Executive Officer of MariMed. “The brand is the market share leader for edibles in Massachusetts, Maryland, and Delaware, and we expect a similar trajectory in Maine. Strategically, this marks another important step forward in our ‘Expand the Brand’ strategy, which focuses on making our award-winning cannabis consumer products available to as many people as possible.”
ABOUT MARIMED
MariMed Inc. is a leading multi-state cannabis operator, known for developing and managing state-of-the-art cultivation, production, and retail facilities. Our award-winning portfolio of cannabis brands, including Betty's Eddies™, Bubby’s Baked™, Vibations™, InHouse™, and Nature’s Heritage™, sets us apart as an industry leader. These trusted brands, crafted with quality and innovation, are recognized and loved by consumers across the country. With a commitment to excellence, MariMed continues to drive growth and set new standards in the cannabis industry. For additional information, visit www.marimedinc.com.
IMPORTANT CAUTION REGARDING FORWARD-LOOKING STATEMENTS:
The information in this release contains “forward-looking” statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, which are subject to several risks and uncertainties. All statements other than statements of historical facts contained in this release, including without limitation statements regarding projected financial results for 2025, including anticipated openings of dispensaries and facilities, timing of regulatory approvals, plans and objectives of management for future operations, are forward-looking statements. Without limiting the foregoing, the words “anticipates”, “believes”, “estimates”, “expects”, “expectations”, “intends”, “may”, “plans”, and other similar language, whether in the negative or affirmative, are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.
Forward-looking statements are based on our current beliefs and assumptions regarding our business, timing of regulatory approvals, the ability to obtain new licenses, business prospects and strategic growth plan, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated in these forward-looking statements due to various risks, uncertainties, and other important factors, including, among others, reductions in customer spending, our ability to recruit and retain key personnel, and disruptions from the integration efforts of acquired companies.
These factors are not intended to be an all-encompassing list of risks and uncertainties that may affect our business and results of operations. These statements are not a guarantee of future performance and involve risk and uncertainties that are difficult to predict, including, among other factors, changes in demand for the Company’s services and products, changes in the law and its enforcement, and changes in the economic environment. Additional information regarding these and other factors can be found in our reports filed with the U.S. Securities and Exchange Commission. In providing these forward-looking statements, the Company expressly disclaims any obligation to update these statements publicly or otherwise, whether as a result of new information, future events or otherwise, except as required by law.
All trademarks and service marks are the property of their respective owners.
Company Contact:
Howard Schacter, Chief Communications Officer
Email: hschacter@marimedinc.com
Phone: (781) 277-0007
FAQ
What is the new licensing agreement between MariMed (MRMD) and The Stoned Moose?
How big is the Maine cannabis market where MRMD is expanding?
Where is Betty's Eddies currently the market share leader?
How will MRMD's expansion in Maine affect its market reach?
When did Betty's Eddies first enter the Maine cannabis market?
